Merck (MRK) Dividends Paid - Common (2009 - 2026)
Merck (MRK) posted quarterly Dividends Paid - Common of $2.1 billion for Q1 2026, up 2.68% YoY from $2.1 billion in Q1 2025, and up 4.31% sequentially from $2.0 billion in Q4 2025.
Merck (MRK) Dividends Paid - Common (2009 - 2026) Analysis & Trends
Merck has disclosed Dividends Paid - Common across 18 years of filings, most recently posting $2.1 billion for Q1 2026.
- In Q1 2026, Dividends Paid - Common rose 2.68% year-over-year to $2.1 billion; the TTM figure through Mar 2026 stood at $8.2 billion (up 3.66% YoY), while the FY2025 annual figure was $8.2 billion, up 4.29% from the prior year.
- Dividends Paid - Common climbed to $2.1 billion in Q1 2026, from $2.0 billion in the prior quarter.
- Over the last five years, Dividends Paid - Common for MRK reached as high as $2.1 billion in Q1 2026 and fell as low as $1.7 billion in Q1 2022.
- The 5-year median for Dividends Paid - Common is $2.0 billion (2024), against an average of $1.9 billion.
- Annual changes were most pronounced in 2022 — Dividends Paid - Common advanced 6.51% — and 2026, when it gained 2.68%.
- A 5-year view of Dividends Paid - Common shows it stood at $1.8 billion in 2022, then grew by 5.83% to $1.9 billion in 2023, then increased by 5.35% to $2.0 billion in 2024, then rose by 3.43% to $2.0 billion in 2025, then increased by 4.31% to $2.1 billion in 2026.
- According to Business Quant data, Dividends Paid - Common over the past three periods registered $2.1 billion, $2.0 billion, and $2.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 1.55 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 3.13 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 3.09 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -3.29 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 2.11 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 1.04 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 2.45 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.11 Bn |
| Mar 31, 2026 | 2.11 Bn |
| Dec 31, 2025 | 2.02 Bn |
| Dec 31, 2025 | 2.02 Bn |
| Sep 30, 2025 | 2.03 Bn |
| Sep 30, 2025 | 2.03 Bn |
| Jun 30, 2025 | 2.08 Bn |
| Jun 30, 2025 | 2.08 Bn |
| Mar 31, 2025 | 2.05 Bn |
| Mar 31, 2025 | 2.05 Bn |
| Dec 31, 2024 | 1.95 Bn |
| Dec 31, 2024 | 1.95 Bn |
| Sep 30, 2024 | 1.95 Bn |
| Sep 30, 2024 | 1.95 Bn |
| Jun 30, 2024 | 1.99 Bn |
| Jun 30, 2024 | 1.99 Bn |
| Mar 31, 2024 | 1.95 Bn |
| Mar 31, 2024 | 1.95 Bn |
| Dec 31, 2023 | 1.85 Bn |
| Dec 31, 2023 | 1.85 Bn |